Oxidative Medicine and Cellular Longevity / 2019 / Article / Fig 2

Research Article

Methylene Blue-Mediated Photodynamic Therapy Induces Macrophage Apoptosis via ROS and Reduces Bone Resorption in Periodontitis

Figure 2

Mitochondrial ROS burst and MMP loss in THP-1 macrophages induced by MB-PDT. (a) Fluorescent photomicrographs of THP-1 macrophages stained with DCFH-DA and MitoSOX depicting increases in intracellular and mitochondrial ROS. The results are expressed as the mean fluorescence intensity of macrophages. (b) Fluorescent photomicrographs of THP-1 macrophages stained with JC-1 to depict the MMP. The results are expressed as the relative mitochondrial membrane potential. (c, d) Cell viability was assessed at 24 h in THP-1 macrophages treated with 20 mM GSH for 1 h, followed by treatment with MB-PDT. The results are expressed as the percentage of viable cells compared with medium alone-treated or MB alone-treated controls (, ). (e) Apoptosis was assessed at 6 h in THP-1 macrophages treated with 20 mM GSH for 1 h, followed by treatment with MB-PDT. The results are expressed as the percentage of apoptotic cells. , , and . . Abbreviations: MB-PDT: methylene blue-mediated photodynamic therapy; DCFH-DA: 2-7-dichlorofluorescein diacetate.
(a)
(b)
(c)
(d)
(e)

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.